AI Summary
This article discusses promising early data from the first-in-human trial of an mRNA-based cancer vaccine for glioblastoma. Additionally, early results from two other trials presented at ESMO are mentioned, indicating potential advancements in cancer treatment.
Results from the first-in-human trial of a new mRNA-based cancer vaccine are promising, as are early results from two other trials presented at ESMO.
Medscape Medical News